COL1A2 has also been implicated in gastric cancer, colorectal cancer, prostate cancer, pancreatic cancer (Yu et al., 2018; Wu et al., 2019; Nie et al., 2020; Liu et al., 2022), and so on. Here, COL1A2 is linked to prostate cancer.